glp-1 without diabetes use tripled among non-diabetics, reaching $5.8B in 2022 Variety of GLP-1 Drugs Help

Likewise, a study published in February 2025 in JAMA Psychiatry found that patients with alcohol-use disorder drank less and had fewer cravings for alcohol and cigarettes over a nine-week treatment period when given a weekly injection of semaglutide

Each tablet contains 32.13 mg sitagliptin phosphate, equivalent to 25 mg sitagliptin

Jemperli is also the first immuno-oncology treatment and PD-1 inhibitor to be authorized for frontline use in this patient population

Tirzepatide works on two hormones instead of one, which tends to produce stronger weight loss results for many patients

Jankovic, J

Semaglutide is a synthetic glucagon-like peptide-1 receptor agonist (GLP-1 RA) developed to overcome the pharmacokinetic limitations of native GLP-1